发布: 2017年01月20日第7卷第2期 DOI: 10.21769/BioProtoc.2113 浏览次数: 11339
评审: Neelanjan BoseAnonymous reviewer(s)
Abstract
This protocol proposes to use the nematode Caenorhabditis elegans as a model to screen and study the anthelmintic activity of natural and synthetic compounds and to observe their effects on the morphology and the ultrastructure of the helminths. Furthermore, C. elegans can be used to investigate the anthelmintic activity in embryonated eggs, larval stages and in the adults’ survival. As most current anthelmintics are not effective against all nematode life stages, this protocol can contribute to the identification of new alternatives to helminthic infections (Sant’Anna et al., 2016).
Keywords: C. elegans (秀丽隐杆线虫)Background
Caenorhabditis elegans is a model organism for parasite nematode research and an excellent system for the screening of compounds with potential anthelmintic activity, because it is inexpensive, readily available, and easy to work with. In addition, the use of C. elegans in assays to investigate nematode behavior, locomotion, reproduction and death is uncomplicated and reliable (Simpkin and Coles, 1981). The protocols for screening new compounds on C. elegans were first carried out in axenic liquid medium in deep well microscope slides (Tomlinson et al., 1985) or using the drugs added to melted modified NGM agar (Driscoll et al., 1989). These methods are not effective in drug screening as axenic cultures, containing low food supply, trigger the intra-uterine birth causing maternal death (endotokia matricida) (Lenaerts et al., 2008) and drugs added to melted agar can modify drug stability due to the high temperatures. In this protocol, we used 96-well plates with liquid medium supplied with Escherichia coli to evaluate each stage (eggs, L1-L2 larvae, L3-L4 larvae and adults) independently.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2017 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Sant’Anna, V., de Souza, W. and Vommaro, R. C. (2017). Assay to Access Anthelmintic Activity of Small Molecule Drugs Using Caenohabidtis elegans as a Model. Bio-protocol 7(2): e2113. DOI: 10.21769/BioProtoc.2113.
分类
生物化学 > 其它化合物 > 小分子药物
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link